Preoperative Portal Vein Embolization for Major Liver Resection: A Meta-Analysis
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Preoperative portal vein embolization (PVE) is used clinically to prevent postoperative liver insufficiency. The current study examined the impact of portal vein embolization on liver resection. METHOD: A comprehensive Medline search to identify all registered literature in the English language on portal vein embolization. Meta-analysis was performed to assess the result of PVE and its impact on major liver resection. RESULT: A total of 75 publications met the search criteria but only 37 provided data sufficiently enough for analysis involving 1088 patients. The overall morbidity rate for PVE was 2.2% without mortality. Four weeks following PVE, 85% patients underwent the planned hepatectomy (n = 930). Twenty-three patients had transient liver failure following resection after PVE (2.5%) but 7 patients developed acute liver failure and died (0.8%). The reason for nonresection following PVE (n = 158, 15%) included inadequate hypertrophy of remnant liver (n = 18), severe progression of liver metastasis (n = 43), extrahepatic spread (n = 35), refusal to surgery (n = 1), poor general condition (n = 1), altered treatment to transcatheter artery embolization or chemotherapy (n = 24), complete remission after treatment with 3 cycles of fluoracil and interferon alpha in a patient with hepatocellular carcinoma (n = 1), incomplete pre- or postembolization scanning (n = 8). Of those who underwent laparotomy without resection, (n = 27) reasons included intraoperative finding of peritoneal dissemination (n = 15), portal node metastasis (n = 2), severe invasion of the tumor to the hepatic artery and portal vein (n = 1), and gross tumoral extension precluding curative resection (n = 9). Two techniques were used for portal vein embolization: percutaneous transhepatic portal embolization, (PTPE) and transileocolic portal embolization, (TIPE). The increase in remnant liver volume was much greater in PTPE than TIPE group (11.9% vs. 9.7%; P = 0.00001). However, the proportion of patients who underwent resection following PVE was 97% in TIPE and 88% PTPE, respectively (P = <0.00001). Although there was no significant difference in patients who had major complications post-PVE, the rate for minor complications was significantly higher among patients who had PTPE (53.6% vs. 0%, P = <0.0001). CONCLUSION: PVE is a safe and effective procedure in inducing liver hypertrophy to prevent postresection liver failure due to insufficient liver remnant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Dindo, D., Demartines, N., & Clavien, P.-A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133083.54934.ae · Cited by 31,378
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Proposed classification of complications of surgery with examples of utility in cholecystectomy.
Clavien, P., Sanabria, J. R., & Strasberg, S. M. (1992) · PubMed · Cited by 1,951
MAKUUCHI, M., Thai, B. L., Takayasu, K., Takayama, T., Kosuge, T., Gunvén, P., Yamazaki, S., Hasegawa, H., & Ozaki, H. (1990) · PubMed · Cited by 1,241
Kubota, K., Makuuchi, M., Kusaka, K., Kobayashi, T., Miki, K., Hasegawa, K., Harihara, Y., & Takayama, T. (1997) · Hepatology · doi:10.1002/hep.510260514 · Cited by 730
Vauthey, J.-N., Chaoui, A., Do, K.-A., Bilimoria, M. M., Fenstermacher, M. J., Charnsangavej, C., Hicks, M., Alsfasser, G., Lauwers, G., Hawkins, I. F., et al. (2000) · Surgery · doi:10.1067/msy.2000.105294 · Cited by 697
Portal Vein Embolization Before Right Hepatectomy: Prospective Clinical Trial
Farges, O., Belghiti, J., Kianmanesh, R., Marc Regimbeau, J., Santoro, R., Vilgrain, V., Denys, A., & Sauvanet, A. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000048447.16651.7b · Cited by 676
Azoulay, D., Castaing, D., Smail, A., Adam, R., Cailliez, V., Laurent, A., Lemoine, A., & Bismuth, H. (2000) · Annals of Surgery · doi:10.1097/00000658-200004000-00005 · Cited by 539
Abdalla, E. K. (2002) · Archives of Surgery · doi:10.1001/archsurg.137.6.675 · Cited by 489
Cited by
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“This approach is associated with a complication rate of 10–20% and occurrence of severe portal hypertension in 1% of cirrhotic patients [191].”
BackgroundRahbari, N. N., Garden, O. J., Padbury, R., Brooke-Smith, M., Crawford, M., Adam, R., Koch, M., Makuuchi, M., Dematteo, R. P., Christophi, C., et al. (2011) · Surgery · doi:10.1016/j.surg.2010.10.001 · Cited by 2,319
Epidemiology and Management of Hepatocellular Carcinoma
Kulik, L., & El-Serag, H. B. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.08.065 · Cited by 1,735
Schnitzbauer, A. A., Lang, S. A., Goessmann, H., Nadalin, S., Baumgart, J., Farkas, S. A., Fichtner-Feigl, S., Lorf, T., Goralcyk, A., Hörbelt, R., et al. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31824856f5 · Cited by 1,332
Hepatocellular carcinoma: a review
Balogh, J., Victor, D., Asham, E. H., Burroughs, S. G., Boktour, M., Saharia, A., Li, X., Ghobrial, M., & Monsour, H. (2016) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s61146 · Cited by 1,185
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
(2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.12.021 · Cited by 1,096
Portal Vein Embolization Before Liver Resection: A Systematic Review
van Lienden, K. P., van den Esschert, J. W., de Graaf, W., Bipat, S., Lameris, J. S., van Gulik, T. M., & van Delden, O. M. (2013) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-012-0440-y · Cited by 471
Hepatocellular Carcinoma: Current Management and Perspectives for the Future
Rahbari, N. N., Mehrabi, A., Mollberg, N. M., Müller, S. A., Koch, M., Büchler, M. W., & Weitz, J. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31820d944f · Cited by 453
Hilar cholangiocarcinoma: expert consensus statement
Mansour, J. C., Aloia, T. A., Crane, C. H., Heimbach, J. K., Nagino, M., & Vauthey, J.-N. (2015) · HPB · doi:10.1111/hpb.12450 · Cited by 414
Liu, C.-Y., Chen, K.-F., & Chen, P.-J. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021535 · Cited by 391
Solbiati, L., Ahmed, M., Cova, L., Ierace, T., Brioschi, M., & Goldberg, S. N. (2012) · Radiology · doi:10.1148/radiol.12111851 · Cited by 366
Liver Resection and Surgical Strategies for Management of Primary Liver Cancer
Orcutt, S. T., & Anaya, D. A. (2018) · Cancer Control · doi:10.1177/1073274817744621 · Cited by 337
Surgery for cholangiocarcinoma
Cillo, U., Fondevila, C., Donadon, M., Gringeri, E., Mocchegiani, F., Schlitt, H. J., Ijzermans, J. N. M., Vivarelli, M., Zieniewicz, K., Olde Damink, S. W. M., et al. (2019) · Liver International · doi:10.1111/liv.14089 · Cited by 335
Dimitroulis, D., Damaskos, C., Valsami, S., Davakis, S., Garmpis, N., Spartalis, E., Athanasiou, A., Moris, D., Sakellariou, S., Kykalos, S., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i29.5282 · Cited by 330
Quality Improvement Guidelines for Percutaneous Transcatheter Embolization
Angle, J. F., Siddiqi, N. H., Wallace, M. J., Kundu, S., Stokes, L., Wojak, J. C., & Cardella, J. F. (2010) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2010.06.014 · Cited by 301
Dhir, M., Melin, A. A., Douaiher, J., Lin, C., Zhen, W. (., Hussain, S. M., Geschwind, J.-F. H., Doyle, M. B. M., Abou-Alfa, G. K., & Are, C. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001556 · Cited by 285
Guiu, B., Chevallier, P., Denys, A., Delhom, E., Pierredon-Foulongne, M.-A., Rouanet, P., Fabre, J.-M., Quenet, F., Herrero, A., Panaro, F., et al. (2016) · European Radiology · doi:10.1007/s00330-016-4291-9 · Cited by 205
Increase in future remnant liver function after preoperative portal vein embolization
de Graaf, W., van Lienden, K. P., van den Esschert, J. W., Bennink, R. J., & van Gulik, T. M. (2011) · British Journal of Surgery · doi:10.1002/bjs.7456 · Cited by 174
“Thirteen patients had evidence of a compromised liver parenchyma in the resection specimen or perioperative biopsy, including biliary fibrosis (1), severe cholestasis (4), steatosis (5) or a combination of these (3).”
BackgroundCurrent evidence on posthepatectomy liver failure: Comprehensive review
Sparrelid, E., Olthof, P. B., Dasari, B. V. M., Erdmann, J. I., Santol, J., Starlinger, P., & Gilg, S. (2022) · BJS Open · doi:10.1093/bjsopen/zrac142 · Cited by 88
Fahrner, R., Patsenker, E., Gottardi, A. D., Stickel, F., Montani, M., Stroka, D., Candinas, D., & Beldi, G. (2014) · Transplantation · doi:10.1097/tp.0000000000000045 · Cited by 47
Metadata
- Authors
- Abulkhir, A., Limongelli, P., Healey, A. J., Damrah, O., Tait, P., Jackson, J., Habib, N., & Jiao, L. R.
- Venue
- Annals of Surgery
- Published
- 2008-01
- Volume
- 247
- Issue
- 1
- Pages
- 49-57
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2071122563
- Cited by
- 673
- References
- 28
- FWCI
- 20.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.